FINWIRES · TerminalLIVE
FINWIRES

VersaBank根據與Stablecorp的協議開始接收QCAD存款;並宣布C$穩定幣已上線Kraken交易所。

-- VersaBank (VBNK.TO) 週一宣布,已開始根據先前公佈的與加拿大數位資產基礎設施公司 Stablecorp 達成的託管服務協議接收 QCAD 存款。 Stablecorp 是 QCAD 數位信託的服務商,其投資者包括 Coinbase、Circle、DeFi Technologies 和 FTP Ventures。 QCAD 是加拿大首個符合監管規定的加幣穩定幣。 VersaBank 也祝賀 Stablecorp 將 QCAD 上線 Kraken。 Kraken 是加拿大註冊的限制性交易商,也是全球歷史最悠久的加密資產交易平台之一。根據上線協議,QCAD 將在 Kraken 上進行交易,從而促進以加元計價的數位資產交易結算。 「QCAD 存款的開始流入不僅進一步驗證了我們的 VersaVault 技術已做好迎接快速增長的數位資產市場的準備,也標誌著 VersaBank 迎來了數位資產策略的首個重要里程碑,實現了我們的首筆新增收入。」總裁 David Taylor 表示。 「預計未來四年內,流通中的穩定幣價值將增長至高達4萬億美元,增長20倍。持牌且受監管的銀行,如同幾個世紀以來一樣,是個人和企業值得信賴的存款保管機構,它們完全有能力繼續履行這一職責。」他補充道。 VersaBank的股票在多倫多證券交易所收盤上漲2.20美元,至24.05美元。

Related Articles

Asia

Update: Origin Energy Reports Lower March Quarter Production; Shares Fall 3%

(Updates to add stock movement in the headline and last paragraph)Origin Energy (ASX:ORG) reported March quarter production of 164.5 petajoules, down from 167.1 petajoules a year earlier, according to a Monday filing with the Australian bourse.The company reported commodity revenue of AU$1.86 billion for the quarter, down from AU$ 2.31 billion a year ago, per the filing.Origin Energy also said its electricity sales volume increased 4% from a year earlier amid "strong growth" in business volumes driven largely by the data-center sector.The company's shares fell 3% in recent Monday trade.

$ASX:ORG
Asia

Alterity Therapeutics Secures US FDA Support for ATH434 Phase Three Program

Alterity Therapeutics (ASX:ATH) said it received positive feedback from a second type C meeting with the US Food and Drug Administration (FDA) on its planned phase three program for drug candidate ATH434, aimed at treating multiple system atrophy (MSA), according to a Monday filing with the Australian bourse.MSA is a progressive neurodegenerative disorder affecting autonomic and motor function with no approved disease-modifying therapies.The US FDA provided supportive written feedback on the program's chemistry, manufacturing, and controls, complementing earlier guidance from a separate type C meeting on clinical pharmacology and non-clinical development, the filing added.

$ASX:ATH
Asia

Xinyuan Property Management's CFO Resigns

Xinyuan Property Management Service's (HKG:1895) chief financial officer, Wang Yong, has resigned, effective April 26, according to a Monday Hong Kong bourse filing.Wang stepped down to devote more time to personal commitments, the company said.The company said the resignation will not affect its normal operations, with Wang's duties to be reallocated internally on an interim basis.Xinyuan Property Management added that it is seeking a suitable replacement for the chief financial officer role.

$HKG:1895